Overview

A Study to Assess CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose.

Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
A Study to Assess the Effect of CT-868 and the Relationship Between Insulin Secretory Response and Ambient Blood Glucose in Obese Male Subjects and Subjects with T2DM.
Phase:
Phase 1
Details
Lead Sponsor:
Carmot Therapeutics, Inc.